On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

André Scheen

ResearcherPublications, citations & collaboration network

André Scheen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does André Scheen have?

ScholarIQindexed works

André Scheen has 1,534 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does André Scheen have?

ScholarIQcitation count

André Scheen has 37,242 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of André Scheen?

ScholarIQh-index

André Scheen has an h-index of 82 in OpenAlex.

What is the i10-index of André Scheen?

ScholarIQi10-index

André Scheen has an i10-index of 365 in OpenAlex.

What is the ORCID of André Scheen?

ScholarIQorcid

The ORCID for André Scheen is on the source record.

What is the OpenAlex record for André Scheen?

ScholarIQopenalex

The OpenAlex for André Scheen is on the source record.

What are the most-cited papers on André Scheen?

ScholarIQmost cited works
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
John Dormandy, B Charbonnel, D.J.A. Eckland, Erland Erdmann, Massimo Massi‐Benedetti, Ian K. Moules, Allan M. Skene, Meng H. Tan, Pierre J. Lefèbvre, Gordon Murray, Eberhard Standl, Robert G. Wilcox, Lars Wilhelmsen, John Betteridge, Kåre I. Birkeland, Alain Golay, Robert J. Heine, László Korányi, Markku Laakso, Marian Mokáň, Antanas Norkus, Valdis Pīrāgs, Toomas Podar, André Scheen, Werner A. Scherbaum, Guntram Schernthaner, Ole Schmitz, J Skrha, Ulf Smith, J Tatoń
The Lancet. 20054,139 CitationsOPEN ACCESS
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Lars Rydén, Peter J. Grant, Stefan D. Anker, Christian Berne, Francesco Cosentino, Nicolas Danchin, Christi Deaton, Javier Escaned, Hans‐Peter Hammes, Heikki Huikuri, Michel Marre, Nikolaus Marx, Linda Mellbin, Jan Östergren, Carlo Patrono, Petar Seferovic, Miguel Sousa‐Uva, Marja-Riita Taskinen, Michał Tendera, Jaakko Tuomilehto, Paul Valensi, José Luis Zamorano, José Luis Zamorano, Stephan Achenbach, Helmut Baumgartner, Jeroen J. Bax, Héctor Bueno, Verónica Dean, Christi Deaton, Çetin Erol, RH Fagard, Roberto Ferrari, David Hasdai, AW Hoes, Paulus Kirchhof, Juhani Knuuti, P Kolh, Patrizio Lancellotti, Aleš Linhart, Petros Nihoyannopoulos, Massimo Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Tamargo, Michał Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Guy De Backer, Per Anton Sirnes, Eduardo Alegría Ezquerra, Angelo Avogaro, Lina Badimón, Е. И. Баранова, Helmut Baumgartner, John Betteridge, Antonio Ceriello, Robert Fagard, Christian Funck‐Brentano, Dietrich C. Gulba, David Hasdai, Arno W. Hoes, John Kjekshus, Juhani Knuuti, P Kolh, Eli Lev, Christian Mueller, Ludwig Neyses, Peter M. Nilsson, Joep Perk, Piotr Ponikowski, Željko Reiner, Naveed Sattar, Volker Schächinger, André Scheen, Henrik Schirmer, Anna Strömberg, Svetlana Sudzhaeva, Juan Tamargo, Margus Viigimaa, Charalambos Vlachopoulos, Robert G. Xuereb
European Heart Journal. 20131,961 CitationsOPEN ACCESS
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Steven C. Griffen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde, Joseph Proietto, Stephen Stranks, Roger Chen, David N. O’Neal, Alexia Pape, Mark Forbes, Claire Morbey, Anton Luger, Ursula Hanusch, Christoph Schnack, Evelyn Fliesser-Goerzer, Bertram Hoelzl, Christoph Ebenbichler, Rudolf Prager, Luc Van Gaal, Chris Vercammen, André Scheen, Chantal Mathieu, Francis Duyck, Frank Nobels, Johannes Ruige, Naresh Aggarwal, Vincent Woo, Bruno St-Pierre, R Dumas, Irene Hramiak, Thomas G. Elliott, Troels Krarup Hansen, Jan Erik Henriksen, Jeppe Gram, Aina S. Lihn, Jens Meldgaard Bruun, Juha Saltevo, Jyrki Taurio, Jorma Strand, Timo T. Valle, Sakari Nieminen, Kirsi H. Pietiläinen, Bruno Guerci, Samy Hadjadj, Bertrand Cariou, Bruno Vergès, Sophie Borot, Alfred Penfornis, Thomas Schaum, Diethelm Tschoepe, Cornelia Marck, Thomas Horacek, Ludger Rose, Gerhard Klausmann, Joerg Luedemann, Steffi Appelt, Ulrich Aigner, R Goebel, Thomas Behnke, Anette‐Gabriele Ziegler, Eva Péterfai, Zsuzsanna Kerenyi, Tamás Oroszlán, G Kiss, L. Könyves, Gyorgyi Piros, Moshe Phillip, Ofri Mosenzon, Naim Shehadeh, Faiad Adawi, Julio Wainstein, Francesco Dotta, PierMarco Piatti, Stefano Genovese, Agostino Consoli, Paolo Di Bartolo, Edoardo Mannucci, Carla Giordano, Annunziata Lapolla, Carlos Aguilar, Alberto Esteban, Bazzoni Ruiz, Guillermo Mondragon Ramirez, Emilia Pelayo Orozco, Carlos Alejandro, Stobschinski de Alba, Carlos Medina Pech, Jose Garza Ruiz, Leobardo Sauque Reyna, Guillermo Llamas Esperón, Luis Alejandro Nevarez Ruiz, Maricela Vidrio Velázquez, Fernando Flores Lozano, José Gerardo González‐González, Pedro Alberto García-Hernández
The Lancet Diabetes & Endocrinology. 2017295 CitationsOPEN ACCESS
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Thomas R. Pieber, Bruce W. Bode, Ann Mertens, Young Min Cho, Erik Christiansen, CHRISTIN L. HERTZ, Signe Olrik Rytter Wallenstein, John B. Buse, Serkan Akın, Nesim Aladağ, Ahmed A. Arif, Louis J. Aronne, S Aronoff, Hayriye Esra Ataoğlu, Sei Hyun Baik, Harold Bays, Patricia Beckett, Dilek Berker, Stefan Bilz, Bruce W. Bode, E Braun, John B. Buse, Luís Henrique Santos Canani, Y M Cho, Choon Hee Chung, Ides M. Colin, Jonathan Condit, John G. Cooper, Bruno Delgado, Donald Eagerton, I N El Ebrashy, Mohamed Hesham Mohamed Fahmy El Hefnawy, Freddy G. Eliaschewitz, MATTHEW FINNERAN, Stefan Fischli, Evelyn Fließer-Görzer, Jeff Geohas, Narendra Godbole, A Golay, SILIVA LAPERTOSA, Jens Gross, Hanne Løvdal Gulseth, F Helland, Hans Olav Høivik, Claire Michael Issa, Eun Seok Kang, Claus Keller, Samir Helmy Assaad Khalil, N H Kim, I J Kim, Leslie J. Klaff, Martin Laimer, Jordan C. Larocque, Samuel Lederman, K-W Lee, W. Reid Litchfield, M B Manning, Ann Mertens, Emily Morawski, Alexander V. Murray, Philip Nicol, Thomas M. O'Connor, Aytekin Oğuz, Sean Wei Xiang Ong, Ali Özdemir, E M Palace, Bryce Palchick, J Pereles-Ortiz, Thomas R. Pieber, Rudolf Prager, Vanessa Preumont, Ernie Riffer, Lucas Rista, Gottfried Rudofsky, RAMAZAN SARI, André Scheen, Bernd Schultes, Ji A Seo, Sara Shelbaya, Kanagaratnam Sivalingam, Christopher Sorli, S Stäuble, Dan Streja, Guy T’Sjoen, Tamer Tetıker, L. Van Gaal, Chris Vercammen, Mark Warren, D. Weinstein, D Weiss, Alexander White, Michael Winnie, Cecilie Wium, Dilek Gogaş Yavuz
The Lancet Diabetes & Endocrinology. 2019277 CitationsOPEN ACCESS
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde, DEPICT-1 Investigators, Joseph Proietto, Stephen Stranks, Roger Chen, David N. O’Neal, Alexia Pape, Mark Forbes, Claire Morbey, Anton Luger, Ursula Hanusch, Christoph Schnack, Evelyn Fliesser-Goerzer, Bertram Hoelzl, Christoph Ebenbichler, Rudolf Prager, Luc Van Gaal, Chris Vercammen, André Scheen, Chantal Mathieu, Francis Duyck, Frank Nobels, Johannes Ruige, Naresh Aggarwal, Vincent Woo, Bruno St-Pierre, R Dumas, Irene Hramiak, Thomas G. Elliott, Troels Krarup Hansen, Jan Erik Henriksen, Jeppe Gram, Aina S. Lihn, Jens Meldgaard Bruun, Juha Saltevo, Jyrki Taurio, Jorma Strand, Timo T. Valle, Sakari Nieminen, Kirsi H. Pietiläinen, Bruno Guerci, Samy Hadjadj, Bertrand Cariou, Bruno Vergès, Sophie Borot, Alfred Penfornis, Diethelm Tschöpe, Thomas Schaum, Cornelia Marck, Thomas Horacek, Ludger Rose, Gerhard Klausmann, Joerg Luedemann, Steffi Appelt, Ulrich Aigner, R Goebel, Thomas Behnke, Anette‐Gabriele Ziegler, Eva Péterfai, Zsuzsanna Kerenyi, Tamás Oroszlán, G Kiss, L. Könyves, Gyorgyi Piros, Moshe Phillip, Ofri Mosenzon, Naim Shehadeh, Faiad Adawi, Julio Wainstein, Francesco Dotta, PierMarco Piatti, Stefano Genovese, Agostino Consoli, Paolo Di Bartolo, Edoardo Mannucci, Carla Giordano, Annunziata Lapolla, Carlos Aguilar, Alberto Esteban Bazzoni Ruiz, Guillermo Mondragon Ramirez, Emilia Pelayo Orozco, Carlos Alejandro Stobschinski de Alba, Carlos Eduardo Medina Pech, Jose Garza Ruiz, Leobardo Sauque Reyna, Guillermo Llamas Esperón, Luis Alejandro Nevarez Ruiz, Maricela Vidrio Velázquez, Fernando Flores Lozano, José Gerardo González‐González, Pedro Alberto García-Hernández, Roberto Araujo Silva, Efraín Villeda-Espinosa
Diabetes Care. 2018240 Citations

Related on ScholarIQ

470M+ articles · free account